Notification Letter and Change Request Form to Registered Shareholder
Filed with HKEX · Stock code 460 · · 2 pages · English and Chinese
The English and Chinese versions of the Company’s Current Corporate Communication are available on the Company’s website at www.sihuanpharm.com and the HKExnews website of The Stock Exchange of Hong Kong Limited (“HKEx”) at www.hkexnews.hk. You may access the Current Corporate Communication by clicking “Investor Relations” section on the homepage of the Company’s website, then selecting under “Fin
Sihuan Pharmaceutical Holdings Group Ltd. on 6ix
Earlier from Sihuan Pharmaceutical
- Interim Report 2026
- Voluntary announcement - insulin aspart 30 injection developed by Sihuan Pharmaceutical achieved equivalent clinical results in efficacy and safety study as originator drug
- Voluntary announcement-entering into strategic cooperation agreement between jilin huisheng biopharmaceutical and porton pharma
- Voluntary announcement - share repurchase
- Voluntary announcement-Sihuan Pharmaceutical obtained drug registration approval in relation to ambroxol hydrochloride injection
Later from Sihuan Pharmaceutical
- Notification Letter and Request Form to Non-registered Holder
- Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2026
- Voluntary announcement - new specifications of skin booster (brand name: dongyan) of Sihuan Pharmaceutical approved for launch by nmpa
- Voluntary announcement-Sihuan Pharmaceutical completed a strategic investment in canton biologics to enhance the layout of the entire industrial chain of regenerative medical aesthetics
Follow Sihuan Pharmaceutical into a list and get an email when it puts out news.
Follow Sihuan Pharmaceutical